Diabetes Diagnostics Market Anticipated To Witness Robust Growth, Surpassing 36.71 Billion By 2029

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Current Diabetes Diagnostics Market Size and Its Estimated Growth Rate?
Over recent years, the market size for diabetes diagnostics has experienced a robust growth. It is anticipated that its value will increase from $25.39 billion in 2024 to $27.39 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors that have propelled the growth during the historical period include the rise in diabetes cases, the expanding population of older adults, a surge in inactive lifestyles, a broader acceptance and adoption of minimally invasive diagnostics, and the growing prevalence of obesity.

Expected to witness significant expansion in the coming years, the diabetes diagnostics market is projected to increase to a valuation of $36.72 billion in 2029, bolstered by a compound annual growth rate (CAGR) of 7.6%. This forecasted growth is largely due to factors such as the growing preference for insulin pumps, continuous developments in diabetes technology, the escalating trend towards unhealthy lifestyles, the rise in cases of type 1 and type 2 diabetes, and the widening of healthcare facilities. Some of the trends to look out for throughout this period include improvements in biosensor technology, technological progress, advancements in diagnosis technologies, precision medicine and targeted treatments, and cutting-edge techniques in in vitro diagnostic goods.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21167

How Are Emerging Segments Shaping the Diabetes Diagnostics Market Landscape?
The diabetes diagnostics market covered in this report is segmented -

1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types
2) By Diabetes Type: Diabetes I, Diabetes II, Gestational Diabetes
3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

Subsegments:
1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-enabled Blood Glucose Meters
2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices
3) By Lancets: Single-use Lancets, Multi-use Lancets
4) By Test Strips: Standard Test Strips, Smart Test Strips
5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood ket*one Meters

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

Which Growth Factors Are Influencing Diabetes Diagnostics Market Expansion?
The rise in obesity rates is predicted to fuel the expansion of the diabetes diagnostics market. Obesity, defined as an extreme buildup of body fat, heightens the likelihood of numerous health issues, including heart disease and diabetes. The escalation in obesity rates is linked to elements such as inactive lifestyles, elevated intake of processed and high-calorie foods, genetic factors, and restricted physical exertion. Diabetes diagnostics aid in managing obesity by detecting issues with insulin resistance and glucose metabolism at an early stage, thus facilitating immediate measures to mitigate weight gain and associated health problems. For example, the Centers for Disease Control and Prevention, a government agency based in the US, reported in September 2023 that in 2022, 22 states had an adult obesity rate of 35% or more, a rise from 19 states in 2021. Consequently, the growing prevalence of obesity is fuelling the expansion of the diabetes diagnostics market.

Who Are the Dominant Players Across Different Diabetes Diagnostics Market Segments?
Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.

What Trends Are Expected to Dominate the Diabetes Diagnostics Market in the Next 5 Years?
Leading corporations in the diabetes diagnostics market are concentrating on the creation of innovative products, like gestational diabetes diagnostic instruments, to augment their selection of offerings and cater to the increasing need for timely detection and management of diabetes during pregnancy. A tool for diagnosing gestational diabetes is defined as medical appliances or tests utilized to identify and observer gestational diabetes in expecting mothers, typically encompassing blood glucose examinations such as the oral glucose tolerance test (OGTT), to evaluate the body's ability to process sugar during pregnancy. For example, in August 2024, an innovative product called the XpressGT RUO kit, a revolutionary biosensor tool devised to identify conditions related to insulin resistance like gestational diabetes, endometriosis, and liver disease, was launched by DirectSens GmbH, a biotechnology firm based in Austria. The kit, which measures 2-hydroxybutyrate (2-HB) levels in venous blood and is harmonious with common clinical analyzers, produces quick results. The intended purpose of this innovation is to facilitate early diagnosis, potentially enhancing the health outcomes for patients globally.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

Which Geographic Regions Are Expected to Dominate the Diabetes Diagnostics Market in the Coming Years?
North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Diabetes Diagnostics Market?
2. What is the CAGR expected in the Diabetes Diagnostics Market?
3. What Are the Key Innovations Transforming the Diabetes Diagnostics Industry?
4. Which Region Is Leading the Diabetes Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.